Power of Technology to Transform Delirium Severity Measurement in the ICU

Overview

About this study

The purpose of this study is to develop a passive digital marker (PDM) for delirium severity and examine its performance in comparison to validated delirium severity tools (CAM-ICU-7, ICDSC).

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Aim 1-3 Patient Participants

  • Age ≥ 50 years old;
  • Estimated length of stay ≥ 24 hours in ICU; and
  • Are not admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal.

Aim 3 Nurse Clinician Participants

  • Age ≥ 18 years old;
  • Employed by Mayo Clinic;
  • Assigned to care for study patient for > 4 hours.

Aim 3 Care Partner Participants

  • Age ≥ 18 years old;
  • Proxy decision maker for patient participant;
  • Willing to complete survey (verbal consent).

Exclusion Criteria:

 

Aim 1-3 Patient Participants

  • Admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal;
  • Admitted for acute neuronal injury;
  • Unable to communicate with research team due to sensory deficits (aphasic, blind, deaf); or
  • Language (does not speak English).

Aim 3 Nurse Clinician Participants

  • Not assigned to study patient.

Aim 3 Care Partner Participants

  • Did not visit patient in ICU during study period;
  • Already listed above in previous protocol version, was not copied/mentioned here.

Eligibility last updated 12/1/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Heidi Lindroth, Ph.D., R.N.

Open for enrollment

Contact information:

Division of Nursing Research Study Team

(507) 422-5523

rstnursingresearch@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Anirban Bhattacharyya, M.D., M.S.

Open for enrollment

Contact information:

Kathleen Leistikow

(507) 422-3994

Leistikow.Kathleen@mayo.edu

Eau Claire, Wis.

Mayo Clinic principal investigator

Heidi Lindroth, Ph.D., R.N.

Open for enrollment

Contact information:

Heidi Lindroth Ph.D., R.N.

(507) 284-3662

Lindroth.Heidi@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Arun Jayaraman, M.D., Ph.D.

Open for enrollment

Contact information:

Kathleen Leistikow

(507) 422-3994

Leistikow.Kathleen@mayo.edu

More information

Publications

Publications are currently not available